|1.||Wu, T-C: 27 articles (07/2015 - 11/2002)|
|2.||Hung, Chien-Fu: 27 articles (01/2015 - 11/2002)|
|3.||Wolchok, Jedd D: 13 articles (01/2013 - 01/2002)|
|4.||Leitner, Wolfgang W: 11 articles (01/2015 - 01/2003)|
|5.||He, Liangmei: 11 articles (03/2010 - 11/2002)|
|6.||Stevenson, Freda K: 10 articles (09/2013 - 03/2002)|
|7.||Houghton, Alan N: 10 articles (01/2013 - 01/2002)|
|8.||Lu, Shan: 9 articles (01/2016 - 07/2006)|
|9.||Wang, Shixia: 9 articles (01/2016 - 07/2006)|
|10.||Weiss, Richard: 9 articles (01/2014 - 01/2003)|
11/01/2001 - "Despite highly promising results in many animal tumor models the efficacy of nucleic acid vaccines and adjuvants in the clinic remains to be seen."
10/01/2010 - "After more than 15 years of experimentation, DNA vaccines have become a promising perspective for tumour diseases, and animal models are widely used to study the biological features of human cancer progression and to test the efficacy of vaccination protocols. "
12/01/2003 - "If these trials prove DNA vaccines to be clinically effective, they could lead to the development of a new generation of therapies for the treatment and/or prevention of cancer."
01/01/2014 - "DNA vaccines require much improvement to make them sufficiently effective against cancer in the clinic. "
08/01/2009 - "In conclusion, xenogeneic immunization with TH-derived DNA vaccines is effective against NB, and may open a new venue for a novel and effective immunotherapeutic strategy against this challenging childhood tumor."
01/01/2010 - "A significant body of studies have addressed the host response to viral infection including the efficacy of DNA vaccines however we still have a fragmented vision of both pathologies associated with viral infection and the immune response to those across fish species. "
03/01/2008 - "Immunizations with IC/DNA vaccines led to an anti-woodchuck hepatitis virus surface antibody response and significant reductions of viral load and antigenemia, suggesting that such a strategy may be effective against chronic HBV infection."
06/01/2003 - "For example, immunization with DNA vaccines expressing the gene for the immunodominant 35000 MW protein, common to Mycobacterium avium and Mycobacterium leprae but absent from the Mycobacterium tuberculosis complex, conferred significant protection against infection with either virulent M. "
03/29/2004 - "These results suggest that in vivo electroporation can be used as an efficient gene delivery system for DNA vaccines to provide efficient protection against viral infection."
07/01/1998 - "Induction of mucosal immunity by targeting DNA vaccines to mucosal surfaces may offer advantages, and an oral vaccine could be effective for controlling infections of the gut mucosa. "
01/01/2009 - "Use of therapeutic DNA vaccines is a promising strategy against tuberculosis (TB), however, their immunogenicity still needs to be improved. "
10/01/2003 - "Immune response and protective efficacy for the combination of four tuberculosis DNA vaccines were evaluated in this study. "
11/01/2001 - "[Evaluation of protective efficacy of two tuberculosis DNA vaccines by lung histopathological analysis]."
01/15/1999 - "Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors."
09/01/1999 - "These results suggest that the tuberculosis DNA vaccines were able to elicit substantial immune responses in suitably vaccinated mice, but further refinements to the constructs or the use of alternative immunization strategies will be needed to improve the efficacy of these vaccine candidates."
|4.||Human Influenza (Influenza)
02/26/2007 - "We conclude that IFN-alpha 6 has antiviral and immunomodulatory effects, which improve efficacy of DNA vaccines for enhanced control of influenza."
01/01/2016 - "Influenza DNA vaccines have been the subject of many studies over the past decades due to their ability to induce broad-based protective immune responses in various animal models. "
06/01/2014 - "This study will provide important information for the selection of adjuvants for DNA vaccines against HPAI H5N1 viruses or other subtypes of human influenza viruses."
07/15/2009 - "In the current study, we evaluated a novel strategy that combines the immunogenicity of influenza VLPs and the advantages of DNA vaccines. "
06/01/2015 - "The novel DNA vaccines could represent a solution to pandemic preparedness in the advent of novel influenza pandemics. "
|5.||Communicable Diseases (Infectious Diseases)
05/01/1997 - "DNA vaccines have been demonstrated to be effective in inducing protective cell-mediated immune responses in animal models of infectious disease. "
08/20/1999 - "The immunogenicity and protective efficacy of DNA vaccines have been amply demonstrated in numerous animal models of infectious disease. "
03/09/2012 - "Our study further demonstrates that the SCT serves as a potent platform for DNA vaccines against various infectious diseases."
12/01/2011 - "Thus, the results of these studies may offer new ways to develop DNA vaccines, as well as delivering novel vaccine adjuvants against infectious diseases."
12/01/2011 - "Furthermore, electroporation has been applied to DNA vaccines for infectious diseases to enhance immunogenicity, and the relevant clinical trials have been initiated. "
|3.||DNA (Deoxyribonucleic Acid)
|4.||Proteins (Proteins, Gene)
|8.||A-Form DNA (A-DNA)
|2.||Drug Therapy (Chemotherapy)
|5.||Fluid Therapy (Oral Rehydration Therapy)